This inventor holds 3 USPTO granted patents. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2000-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Waterbury, CT (US) (2000)
- Brookfield, CT (US) (2002 - 2011)
Company Filing History:
Years Active: 2000-2011
Title: George A. DeStefano: Innovator in Pharmaceutical Formulations
Introduction
George A. DeStefano is a notable inventor based in Waterbury, CT (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of metered dose inhalers. With a total of 3 patents to his name, DeStefano's work has had a meaningful impact on respiratory therapies.
Latest Patents
DeStefano's latest patents include a formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants. This invention describes an improved suspension formulation that incorporates a controlled addition of a small quantity of water. Another significant patent focuses on pharmaceutical formulations for aerosols containing two or more active substances. This invention relates to new pharmaceutical preparations for propellant-driven metered dose aerosols using a fluorohydrocarbon (HFC) as propellant, which includes a combination of active substances, with at least one being in dissolved form alongside another in suspended particles.
Career Highlights
George A. DeStefano is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc. His work at this esteemed company has allowed him to further his research and development in innovative pharmaceutical solutions.
Collaborations
DeStefano has collaborated with several talented individuals in his field, including Daniel P. McNamara and Linda Jean Kelash-Cannavo, who is a woman. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
George A. DeStefano's contributions to pharmaceutical formulations demonstrate his commitment to innovation in respiratory therapies. His patents reflect a deep understanding of the complexities involved in aerosol delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
